Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.
Follow MDT
Medtronic PLC (MDT) EV/FCF
As of 16 October 2026, Medtronic PLC (MDT) trades at a EV/FCF of 22.9×. Over the past ten years it has ranged from 12.4× (January 2015) to 41.6× (April 2021); the current reading is higher than 18% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2026 | 22.6× | (8.90%) |
| FY2025 | 24.8× | 4.32% |
| FY2024 | 23.8× | (20.56%) |
| FY2023 | 29.9× | 17.64% |
| FY2022 | 25.4× | (35.19%) |
| FY2021 | 39.2× | 63.20% |
| FY2020 | 24.0× | 4.54% |
| FY2019 | 23.0× | (32.53%) |
| FY2018 | 34.1× | 41.82% |
| FY2017 | 24.0× | (23.07%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jul 2026 | 21.0× | (7.12%) |
| Apr 2026 | 22.6× | (19.32%) |
| Jan 2026 | 28.0× | 6.32% |
| Oct 2025 | 26.3× | 2.54% |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| PHG Koninklijke Philips N.V. compare | 16.1× |
| BSX Boston Scientific Corporation compare | 21.3× |
| MDT Medtronic PLC | 22.9× |
| DXCM DexCom, Inc. compare | 23.5× |
| STE STERIS plc compare | 24.7× |
| GEHC GE HealthCare Technologies Inc. compare | 25.9× |
| SYK Stryker Corporation compare | 26.5× |
| ABT Abbott Laboratories compare | 26.8× |
| EW Edwards Lifesciences Corporation compare | 33.4× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on MDT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement